financetom
Business
financetom
/
Business
/
Dieselgate trial of former VW chief suspended due to ailing health
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Dieselgate trial of former VW chief suspended due to ailing health
Oct 2, 2024 10:11 PM

BERLIN, Germany (Reuters) - The criminal trial of former Volkswagen Chief Executive Martin Winterkorn over the so-called dieselgate scandal has been suspended due to his poor health, a court in Braunschweig said on Tuesday.

All hearings have been cancelled because Winterkorn, who was toppled from the helm of the company in 2015 after it emerged that millions of Volkswagen cars had been manipulated to pass environmental standards, will not be fit to attend in the coming months, the court said.

The first quarter of 2025 is now being considered as a new timeframe for the start of the 77-year-old's trial, the culmination of a case more than five years in the making.

The criminal charges against Winterkorn include fraud, market manipulation and unlawful false testimony before a parliamentary committee.

   He is also alleged to have failed to inform the capital market in good time about the mass manipulation of diesel engines in 2015.

At the start of the trial in September, Winterkorn said via his lawyer that he "did not defraud or harm anyone" and "did not deliberately leave the capital market in the dark so that investors would be harmed".

The suspension comes as the future of Volkswagen's German locations is in question and the carmaker looks for billions of euros in savings at its namesake brand.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Market Chatter: Chevron Expected to Receive Formal Bids From Vitol, Glencore for Singapore Refinery Stake
Market Chatter: Chevron Expected to Receive Formal Bids From Vitol, Glencore for Singapore Refinery Stake
Sep 17, 2025
06:29 AM EDT, 09/17/2025 (MT Newswires) -- Chevron ( CVX ) is expected to receive formal bids from Vitol and Glencore for the US oil giant's 50% stake in Singapore's second-largest refinery, Reuters reported Wednesday, citing people familiar with the matter. The entire refinery is valued at $1 billion, the report said. The Switzerland-based commodities traders were shortlisted this month...
Huize Gets License in Singapore for Poni
Huize Gets License in Singapore for Poni
Sep 17, 2025
06:31 AM EDT, 09/17/2025 (MT Newswires) -- Huize Holding ( HUIZ ) said Wednesday that Poni Financial Advisory was licensed by the Monetary Authority of Singapore as a financial adviser and exempt insurance broker. The move marks a key step in the company's international expansion, with Singapore and Hong Kong serving as its hubs, it said. Huize ( HUIZ )...
Commerzbank on Overnight News
Commerzbank on Overnight News
Sep 17, 2025
06:23 AM EDT, 09/17/2025 (MT Newswires) -- Commerzbank in its European Sunrise note of Wednesday highlighted: Markets: Unite States Treasuries remain supported after a solid 20-year auction. Equities are softer. EUR consolidates after hitting new high above $1.187. Oil slightly lower after Tuesday's rally. Fed: White House nominee Stephen Miran was sworn in as Federal Reserve governor. Trump to ask...
Celldex Therapeutics Says Barzolvolimab Data Shows Sustained Efficacy in Chronic Spontaneous Urticaria
Celldex Therapeutics Says Barzolvolimab Data Shows Sustained Efficacy in Chronic Spontaneous Urticaria
Sep 17, 2025
06:22 AM EDT, 09/17/2025 (MT Newswires) -- Celldex Therapeutics ( CLDX ) said Wednesday that new data from a study of barzolvolimab showed rapid and strong efficacy regardless of baseline immunoglobulin E levels in patients with chronic spontaneous urticaria. The results showed similar improvements in urticaria activity scores and rates of disease control in both low and normal or high...
Copyright 2023-2026 - www.financetom.com All Rights Reserved